IT1298155B1 - Composti pirimidin 3-ossido per il trattamento delle patologie muscolo-scheletriche, in particolare per il trattamento della - Google Patents

Composti pirimidin 3-ossido per il trattamento delle patologie muscolo-scheletriche, in particolare per il trattamento della

Info

Publication number
IT1298155B1
IT1298155B1 ITMI980086A IT1298155B1 IT 1298155 B1 IT1298155 B1 IT 1298155B1 IT MI980086 A ITMI980086 A IT MI980086A IT 1298155 B1 IT1298155 B1 IT 1298155B1
Authority
IT
Italy
Prior art keywords
treatment
pyridid
muscle
oxide compounds
skeletal pathologies
Prior art date
Application number
Other languages
English (en)
Inventor
Moreno Paolini
Domenico Tricarico
Original Assignee
Moreno Paolini
Domenico Tricarico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moreno Paolini, Domenico Tricarico filed Critical Moreno Paolini
Priority to ITMI980086 priority Critical patent/IT1298155B1/it
Priority to PCT/EP1999/000269 priority patent/WO1999036072A1/en
Priority to EP99904793A priority patent/EP1049473A1/en
Publication of ITMI980086A1 publication Critical patent/ITMI980086A1/it
Application granted granted Critical
Publication of IT1298155B1 publication Critical patent/IT1298155B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
ITMI980086 1998-01-19 1998-01-19 Composti pirimidin 3-ossido per il trattamento delle patologie muscolo-scheletriche, in particolare per il trattamento della IT1298155B1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI980086 IT1298155B1 (it) 1998-01-19 1998-01-19 Composti pirimidin 3-ossido per il trattamento delle patologie muscolo-scheletriche, in particolare per il trattamento della
PCT/EP1999/000269 WO1999036072A1 (en) 1998-01-19 1999-01-18 Pyrimidin 3-oxide compounds suitable for the treatment of pathologies of the skeletal muscle, in particular for the treatment of the hypokalemic paralysis
EP99904793A EP1049473A1 (en) 1998-01-19 1999-01-18 Pyrimidin 3-oxide compounds suitable for the treatment of pathologies of the skeletal muscle, in particular for the treatment of the hypokalemic paralysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI980086 IT1298155B1 (it) 1998-01-19 1998-01-19 Composti pirimidin 3-ossido per il trattamento delle patologie muscolo-scheletriche, in particolare per il trattamento della

Publications (2)

Publication Number Publication Date
ITMI980086A1 ITMI980086A1 (it) 1999-07-19
IT1298155B1 true IT1298155B1 (it) 1999-12-20

Family

ID=11378623

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI980086 IT1298155B1 (it) 1998-01-19 1998-01-19 Composti pirimidin 3-ossido per il trattamento delle patologie muscolo-scheletriche, in particolare per il trattamento della

Country Status (3)

Country Link
EP (1) EP1049473A1 (it)
IT (1) IT1298155B1 (it)
WO (1) WO1999036072A1 (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1323432B1 (en) * 2001-12-28 2005-08-24 Sandra Cosci Complexes of cyclodextrins with potassium ion homeostasis regulators
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
JP5133416B2 (ja) 2007-09-14 2013-01-30 オルソー−マクニール−ジャンセン ファーマシューティカルズ， インコーポレイテッド． １’，３’−二置換−４−フェニル−３，４，５，６−テトラヒドロ−２ｈ，１’ｈ−［１，４’］ビピリジニル−２’−オン
US8691849B2 (en) 2008-09-02 2014-04-08 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
WO2010060589A1 (en) 2008-11-28 2010-06-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
US8937060B2 (en) 2009-05-12 2015-01-20 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EP2430031B1 (en) 2009-05-12 2013-04-17 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
AU2011328195B2 (en) 2010-11-08 2015-04-02 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
WO2012062750A1 (en) 2010-11-08 2012-05-18 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
IL279202B2 (en) 2014-01-21 2023-09-01 Janssen Pharmaceutica Nv Combinations containing positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic subtype 2 receptor and their use
PL3431106T3 (pl) 2014-01-21 2021-06-28 Janssen Pharmaceutica Nv Kombinacje zawierające pozytywne modulatory allosteryczne metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2055376A1 (en) * 1990-12-05 1992-06-06 Gary J. Grover Method of treating shock using a potassium channel activator

Also Published As

Publication number Publication date
EP1049473A1 (en) 2000-11-08
WO1999036072A1 (en) 1999-07-22
ITMI980086A1 (it) 1999-07-19

Similar Documents

Publication Publication Date Title
DE69924365D1 (de) Massagegerät
IT1298155B1 (it) Composti pirimidin 3-ossido per il trattamento delle patologie muscolo-scheletriche, in particolare per il trattamento della
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
FI20000863A (fi) Uusi hoitomenetelmä
SG77244A1 (en) Nefazodone dosage form
NO20005179D0 (no) Medikament behandling
DK1022396T3 (da) Bruserkombination
EE200200047A (et) Ekstsentrikajamiga hambahari
DE69928004D1 (de) Badewanne
IT1306165B1 (it) Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi.
DE60042276D1 (de) Stromloses plattierungsverfahren
PT1176982E (pt) Solucao oral de prucaloprida
FI19992741A (fi) Karsintalaitteisto
DE29807618U1 (de) Massagegerät
DE59904743D1 (de) Exzenteranordnung
DE29822274U1 (de) Saunaliege
DE29905419U1 (de) Duschabtrennung
CA93752S (fr) Baignoire
FR2788967B1 (fr) Table de massage
DE29811605U1 (de) Massageliege
DE29807094U1 (de) Massagegerät
DE29810738U1 (de) Massagegerät
DE60004956D1 (de) Diamantbeschichtetes Gleitteil
DE50015729D1 (de) Exzenterpresse
DE29900357U1 (de) Duschabtrennung

Legal Events

Date Code Title Description
0001 Granted